en
Scientific article
English

Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA

Published inRheumatology
Publication date2019
Abstract

To investigate TNF inhibitor (TNFi) retention and response rates in European biologic-naïve patients with PsA.

Keywords
  • DAPSA28
  • DAS28
  • TNFi
  • Drug survival
  • Effectiveness
  • Epidemiology
  • Psoriatic arthritis
  • Register
  • Response
  • Spondyloarthritis
Citation (ISO format)
BRAHE, Cecilie Heegaard et al. Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. In: Rheumatology, 2019. doi: 10.1093/rheumatology/kez427
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1462-0324
189views
0downloads

Technical informations

Creation12/05/2019 11:02:00 AM
First validation12/05/2019 11:02:00 AM
Update time03/15/2023 9:52:11 PM
Status update03/15/2023 9:52:09 PM
Last indexation01/17/2024 9:44:19 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack